You are here: Industry Insights > mRNA

News List

Study Reveals Huge Potential for mRNA Drug Targets biospace
March 20, 2018
Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market space.
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial biospace
November 17, 2017
Moderna Therapeutics announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a messenger RNA (mRNA)-based personalized cancer vaccine.
Lilly, CureVac pen $1.8B mRNA cancer vaccine deal fiercebiotech
October 19, 2017
Lilly is making a $50 million upfront payment and €45 million equity investment to get the deal up and running.
AstraZeneca strikes mRNA-based partnership in respiratory disease pharmatimes
August 23, 2017
AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist Ethris to leverage the latter’s proprietary SNIM RNA technology in the...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page